FAM225A and nasopharyngeal carcinoma: Similarly, FAM225A exerts a ceRNA effect and competes for binding to miR‐590‐3p and miR‐1275, thereby reducing their inhibitory effect on ITGβ3 and promoting proliferation and invasion of nasopharyngeal carcinoma cells.50